Intravenous Beta-Blockers for Cardioprotection in STEMI: The Saga Continues

Journal of the American College of Cardiology

Volumn 67, Issue 23, 2016, Pages 2716-2718

  Newby, L Kristin ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

cardiac magnetic resonance; ejection fraction; infarct size; metoprolol

Indexed keywords

METOPROLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

CAUSE OF DEATH; DRUG EFFECT; DRUG SAFETY; EDITORIAL; HEART INFARCTION SIZE; HEART MUSCLE OXYGEN CONSUMPTION; HEART PROTECTION; HUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT PLANNING; HEART INFARCTION;

ADRENERGIC BETA-ANTAGONISTS; HUMANS; METOPROLOL; MYOCARDIAL INFARCTION; ST ELEVATION MYOCARDIAL INFARCTION;

EID: 84978249259     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.03.532     Document Type: Editorial

References (7)

1. 1 Fordyce, C.B., Gersh, B.J., Stone, G.W., Granger, C.B., Novel therapeutics in myocardial infarction: targeting microvascular dysfunction and reperfusion injury. Trends Pharmacol Sci 36 (2015), 605–616.
2. 2 Lonborg, J.T., Targeting reperfusion injury in the era of primary percutaneous coronary intervention: hope or hype?. Heart 101 (2015), 1612–1618.
3. 3 Ibanez, B., Prat-Gonzalez, S., Speidl, W.S., et al. Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance. Circulation 115 (2007), 2909–2916.
4. 4 Chen, Z.M., Pan, H.C., Chen, Y.P., et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomized placebo-controlled trial. Lancet 366 (2005), 1622–1632.
5. 5 Ibáñez, R., Macaya, C., Sanchez-Brunete, V., et al. Effect of early metoprolol on infarct size in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial. Circulation 128 (2013), 1495–1503.
6. 6 Roolvink, V., Ibáñez, B., Ottervanger, J.P., et al. Early intravenous beta-blockers in patients with ST-segment elevation myocardial infarction before primary percutaneous coronary intervention. J Am Coll Cardiol 67 (2016), 2705–2715.
7. 7 Ndrepepa, G., Kastrati, A., Intravenous β-blockers in primary percutaneous coronary intervention: new hope for an old therapy. Circulation 128 (2013), 1487–1489.